The Management of Hypertension and Gout Arthritis in 71 Years Old Female Patients at Tanjung Sari Natar Health Center through a Family Medicine Approach
penatalaksaan hipertensi dan gout artritis
DOI:
https://doi.org/10.53089/medula.v12i1.323Keywords:
gout artritis hipertensiAbstract
The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health threat worldwide with millions of people at risk in a growing number of countries. Though there are no clinically approved antiviral drugs and vaccines for COVID-19, attempts are ongoing for clinical trials of several known antiviral drugs, their combination, as well as development of vaccines in patients with confirmed COVID-19. This review focuses on the latest approaches to diagnostics and therapy of COVID-19. We have summarized recent progress on the conventional therapeutics such as antiviral drugs, vaccines, anti-SARS-CoV-2 antibody treatments, and convalescent plasma therapy which are currently under extensive research and clinical trials for the treatment of COVID-19. The developments of nanoparticle-based therapeutic and diagnostic approaches have been also discussed for COVID-19. We have assessed recent literature data on this topic and made a summary of current development and future perspectives.
References
Ikawati Z, Djumiani S, Putu ID. Keamanan obat anti-hipertensi di poliklinik usia lanjut instalasi rawat jalan RS. DR. Sardjito. Majalah Ilmu Kefarmasian. 2008; 10(3):150-69.
Suhardjono. Buku ajar ilmu penyakit dalam: geriatri dan gerontology; hipertensi pada usia lanjut. Jakarta: Pusat penerbitan Ilmu Penyakit Dalam. 2014; 6(1): 3855-58.
Pusat Data dan Informasi Kementrian Kesehatan Republik Indonesia. Situasi dan Analisis Lanjut Usia. Tersedia dari : http://www.depkes.go.id/resources/download /pusdatin/infodatin/infodatin-asi.pdf
Khanna A. Guidelines for management of gout: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. American College of Rheumatology. 2012; 10(6):1431- 1446.
Khanna A. Guidelines for management of gout: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. American College of Rheumatology. 2012; 10(6):1447-1461.
Kuo EA. Gout: an independent risk factor for allcause and cardiovascular mortality. Rheumatology Oxford. 2010; 4(1): 141-146.
Liebman S. Urid acid nephrolithiasis. Current Rheumatology Reports. 2007; 9(3): 251-257.
Kaplan NM, Rose BD. Up to date: treatment of hypertension in the elderly patient. Particularly isolated systolic hypertension. Tersedia dari: http://www. UpToDate/ contents/mobipreview.htm?18/21/18769
Chobanian AV, George LB, Henry R. American Heart Association: The seventh report of the Joint national committee 8 on prevention, detection, evaluation, and treatment of high blood pressure. 2014 [disitasi tanggal 5 november 2014]. Tersedia dari http://hyper.ahajournals.org/
Syed Q, Barbara MR. Current diagnosis & treatment geriatrics: hypertension. Mc Graw Hill Education, North America: Internationaledition. 2014; 30: 202-12.
Sarah J. The HYVET study: answering the question of wther or not to treat hypertension in the very elderly. Primay Care Cardiovascular Journal; 2008.
Giueseppe M. American Heart Association: effects of intensive blood pressure control in the management of patients with type 2 diabetes mellitus in the action to control cardiovascular risk in diabetes ( ACCORD). Trial Circulation. 2010;122:847-49.
Mandell BF. Clinical manifestations of hyperuricemia and gout. Cleveland Clinic Journal of Medicine. 2008; 75(5): S5-S8.
Muniroh A. Minyak atsiri kunyit sebagai anti radang pada penderita gout artritis dengan fiet tinggi purin. Makara Kesehatan. 2010; 14(2):58.
Nainggolan O. Prevalensi dan determinan penyakit rematik di Indonesia. Majalah Kedokteran Indonesia. 2009; 59(12): 589.
Suhardjono. Naskah lengkap the 11th Jakarta Nephrology and Hypertension Course and Symposium on Hypertension: hipertensi pada usia lanjut. Jakarta: PERNEFRI (Perhimpunan Nefrologi Indonesia). 2011; 1(1):113-16.
Lawrence J, Appel, Mark A, Espeland. Effects of reduced sodium intake on hypertension control in older individuals: results from the trial of nonpharmacologic interventions in the elderly (TONE). Arch Intern Med. 161:685- 93.
Willbert SA, Jerome L, Fleg, Carl JP. ACCF/AHA expert consensus document on hypertension the elderly. Jornal of the American College of Cardiology; 2011.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
